Latest Posts

22

Apr 24

Partex Partners with Lupin to Revolutionize Drug Discovery through AI-Driven Asset Search and Evaluation

Frankfurt, Germany, 23 April 2024 – Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled to...
Read More

27

Mar 24

Partex NV announces collaboration with Althea DRF Lifesciences to provide comprehensive end-to-end services to accelerate drug discovery and development

Frankfurt, Germany; 28 March 2024 – Partex Group, a pioneer in AI-driven drug discovery, announces a collaboration with Althea DRF...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More

Category: Media

Building AI Foundation

How to build the foundations of AI your team needs?- A deep dive. Gaurav Tripathi, Co-Founder and CTO of Innoplexus, shares his experience as a data scientist and entrepreneur who embraces the challenges of AI. Learn about building the foundations of Life Sciences and Healthcare AI for continuous analytics by embracing failure in the right …

Building AI Foundation Read More »

INNOPLEXUS INCLUDED AGAIN IN GARTNER HYPE CYCLE FOR LIFE SCIENCES

Eschborn, January 2019. The world-renowned US analyst firm Gartner Inc. annually publishes its Hype Cycle for Life Sciences to help C-Level understand innovative technology, prioritize investments and drive organizational change. The latest reported included Innoplexus AG, a leading provider of artificial intelligence (AI) for a second year in a row. Gartner sees Innoplexus as a …

INNOPLEXUS INCLUDED AGAIN IN GARTNER HYPE CYCLE FOR LIFE SCIENCES Read More »

Innoplexus Brings Blockchain to Pharma

Global AI firm Innoplexus launched an innovative blockchain platform to dramatically raise the amount of data available for drug research and discovery. This new platform, an update to Innoplexus’ flagship product iPlexus is the first of its kind and will enable researchers to upload and license unpublished data on the blockchain to facilitate collaboration, reduce …

Innoplexus Brings Blockchain to Pharma Read More »

Founder fights cancer with artificial intelligence

Gunjan Bhardwaj helps pharmaceutical companies to find out more about diseases. By harnessing artificial intelligence, pharmaceutical companies are able to develop drugs more quickly. Frankfurt. It was a life-changing experience for Gunjan Bhardwaj to have a dear friend diagnosed with cancer years ago. In a desperate attempt to help, Bhardwaj, an Indian-born businessman, scavenged the …

Founder fights cancer with artificial intelligence Read More »

Google for Pharma

Indian and Swabian Together with friends from India, Gunjan Bhardwaj has successfully launched Innoplexus, a sophisticated ecosystem of continuous analytics, powered by artificial intelligence and machine learning.The goal: Innoplexus wants to become the European champion for AI. The chances: excellent. At 35, Gunjan Bhardwaj was an aspiring management consultant at Ernst & Young. The atmosphere …

Google for Pharma Read More »

We want to democratize data

Dr. Gunjan Bhardwaj is the founder and CEO of Innoplexus AG. With the help of artificial intelligence, blockchain and big data analysis applications, its iPlexus software has crawled over 300 terabytes of relevant clinical and medical data and put them in a logical context, being constantly updated and delivered to the workstations of customers in …

We want to democratize data Read More »